Article Details

FDA Accepts Biologics License Application for Infant RSV Antibody

Retrieved on: 2024-12-17 18:45:37

Tags for this article:

Click the tags to see associated articles and topics

FDA Accepts Biologics License Application for Infant RSV Antibody. View article details on hiswai:

Excerpt

Clesrovimab is an investigational extended half-life monoclonal antibody designed to be administered as a single dose, regardless of weight. While ...

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo